Home / Stocks / Global Health Limited
MEDANTA

Global Health Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,478.3

Change

+41.7 (2.9%)

Open

₹1,436.6

Prev. Close

₹1,436.6

Day High

₹1,485.5

Day Low

₹1,432.7

Volume Analysis

Traded

282,387

Delivered

183,933

Delivery %

65.14%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (22.0%)

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (19.4%)
  • •Strong 3-year revenue growth (17.6%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,551.1 ₹1,518.3 ₹1,498.3 ₹1,465.5 ₹1,445.5 ₹1,412.7 ₹1,392.7
Fibonacci ₹1,518.3 ₹1,498.13 ₹1,485.67 ₹1,465.5 ₹1,445.33 ₹1,432.87 ₹1,412.7
Camarilla ₹1,492.82 ₹1,487.98 ₹1,483.14 ₹1,465.5 ₹1,473.46 ₹1,468.62 ₹1,463.78

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+24.03%

1 Week

+2.68%

1 Month

+19.95%

3 Months

+4.87%

6 Months

+19.4%

1 Year

+21.86%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹273.84

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

12.43%

Net margin 12.13% × asset turnover 0.67x × equity multiplier 1.53x

Company Overview

Sector

Healthcare

Market Cap

₹38,864 Cr

P/E (TTM)

60.0

ROE

15.2%

Book Value

₹161.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Global Health Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 69/100. The strongest factor is Financial Strength (99/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

69/100 — Good

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

99

Growth

96

Valuation

0

Cash Flow

66

Corporate Governance

48

Momentum

83

Institutional Ownership

50

Business Quality

76

Risk & Volatility

69

Liquidity

95

From Screener.in

  • +Company has delivered good profit growth of 80.7% CAGR over last 5 years
  • −Stock is trading at 8.96 times its book value

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.

Investor Presentation for the Analyst/Investors Meet .

Global Health schedules one-on-one investor meetings on November 19-20, 2026 with several global asset managers.

Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.

Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 844 836 809 861 957 943 931 1,031 1,099 1,121 1,159 1,304 1,469
Expenses + 631 620 629 675 728 706 707 784 868 904 915 1,017 1,099
Operating Profit 213 216 179 186 228 238 225 247 231 217 244 287 370
OPM % 25.0% 26.0% 22.0% 22.0% 24.0% 25.0% 24.0% 24.0% 21.0% 19.0% 21.0% 22.0% 25.0%
Other Income + 21 18 27 22 18 16 -27 20 36 -15 37 22 24
Interest 20 18 18 18 16 16 15 14 17 22 27 27 28
Depreciation 43 44 45 47 49 48 49 45 50 61 67 69 71
Profit before tax 171 172 143 144 181 189 133 208 200 120 187 213 295
Tax % 27.0% 28.0% 11.0% 26.0% 28.0% 24.0% 24.0% 24.0% 21.0% 21.0% 24.0% 26.0% 26.0%
Net Profit + 125 124 127 106 131 143 101 159 158 95 142 157 219
EPS in Rs 5 5 5 4 5 5 4 6 6 4 5 6 8
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 24 20 14 10 13 13 15 20 15 19 24 26 34

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 1,382 1,343 1,456 1,500 1,447 2,167 2,710 3,275 3,692 4,410 5,053
Expenses + 1,081 1,218 1,283 1,309 1,250 1,709 2,073 2,466 2,806 3,480 3,935
Operating Profit 301 125 172 192 197 458 637 809 886 930 1,118
OPM % 22.0% 9.0% 12.0% 13.0% 14.0% 21.0% 24.0% 25.0% 24.0% 21.0% 22.0%
Other Income + 45 49 50 44 31 39 49 75 29 98 68
Interest 14 28 38 57 73 86 86 84 74 90 103
Depreciation 70 86 102 115 123 130 150 173 194 223 267
Profit before tax 262 60 83 64 32 281 449 627 647 715 815
Tax % 35.0% 45.0% 38.0% 43.0% 11.0% 30.0% 27.0% 24.0% 26.0% 23.0% —
Net Profit + 170 33 51 36 29 196 326 478 481 554 613
EPS in Rs 7 1 2 1 1 8 12 18 18 21 23
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.0% —
Sales growth — — 8 3 -4 50 25 21 13 19 26

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 976 1,136 1,246 1,300 1,333 1,565 2,375 2,852 3,333 3,908 4,270
Borrowings + 165 456 787 929 931 1,109 1,122 802 718 1,190 1,353
Other Liabilities + 295 343 347 388 380 421 547 572 662 753 930
Total Liabilities 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905 6,606
Fixed Assets + 914 1,094 1,194 1,703 1,616 1,776 2,050 2,236 2,514 3,795 3,957
CWIP 12 317 666 382 464 439 327 388 533 132 207
Investments 0 0 0 0 0 0 0 0 3 3 3
Other Assets + 559 573 570 581 615 930 1,720 1,656 1,716 1,975 2,440
Total Assets 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905 6,606
Equity Capital 48 48 49 49 50 51 54 54 54 54 54

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 228 63 166 175 242 311 645 612 624 714
Cash from Investing Activity + -241 -69 -249 -87 -239 -421 -342 -441 -721 -1,089
Cash from Financing Activity + -7 9 97 -1 -81 160 346 -514 -97 272
Net Cash Flow -20 3 14 87 -78 50 648 -343 -194 -103
Free Cash Flow 71 -81 -133 -13 100 38 409 335 110 -123
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 108 93 135 121 131 89 118 98 89 90

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 33.05% → 33.0%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.06% 0.06% 0.06% 0.08% 0.09% 0.12%
Public 44.45% 44.6% 43.44% 43.64% 43.98% 43.28% 43.19% 42.56% 42.41% 42.01% 40.55% 39.96%
Promoters 33.05% 33.04% 33.04% 33.04% 33.03% 33.03% 33.01% 33.01% 33.01% 33.01% 33.0% 33.0%
FII 11.36% 12.1% 12.94% 12.21% 12.48% 11.76% 11.54% 11.41% 10.54% 10.15% 9.46% 9.92%
DII 11.15% 10.25% 10.57% 11.11% 10.51% 11.93% 12.2% 12.97% 13.99% 14.76% 16.89% 17.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Global Health Limited (this stock) 38,864 60.0 8.97 15.2%
Sai Life Sciences Limited 38,018 99.5 14.08 15.4%
Narayana Hrudayalaya Ltd. 37,889 41.8 7.57 20.5%
Ajanta Pharma Limited 41,393 32.8 8.51 27.1%
Dr. Lal Path Labs Ltd. 33,582 55.5 12.2 22.3%
Emcure Pharmaceuticals L 44,370 39.9 8.29 20.1%
Wockhardt Limited 32,944 82.4 6.39 6.11%

Which Mutual Funds Hold Global Health Limited?

Frequently Asked Questions about Global Health Limited

Community Sentiment

What are other investors saying about Global Health Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.